OPTINOSE INC. - COMMO

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

22 Nov 2023 08:00:00 By Nasdaq GlobeNewswire

Optinose Reports Third Quarter 2023 Financial Results and Operational Updates

09 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

Optinose Announces Reporting Date for Third Quarter 2023 Financial Results

27 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Optinose to Present at the 2023 Cantor Global Healthcare Conference

22 Sep 2023 08:01:00 By Nasdaq GlobeNewswire

Optinose Reports Second Quarter 2023 Financial Results and Operational Updates

10 Aug 2023 06:00:00 By Nasdaq GlobeNewswire

Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million

27 Jul 2023 06:00:01 By Nasdaq GlobeNewswire

Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

16 Jun 2023 15:08:00 By Nasdaq GlobeNewswire

Optinose to Present at the Jefferies Healthcare Conference

02 Jun 2023 12:00:00 By Nasdaq GlobeNewswire

Optinose Reports First Quarter 2023 Financial Results and Operational Updates

11 May 2023 06:00:18 By Nasdaq GlobeNewswire

Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE

04 May 2023 06:00:01 By Nasdaq GlobeNewswire

Optinose Announces Reporting Date for First Quarter 2023 Financial Results

01 May 2023 15:30:00 By Nasdaq GlobeNewswire

Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

18 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Optinose to Present at the Needham Virtual Healthcare Conference

12 Apr 2023 15:00:00 By Nasdaq GlobeNewswire

Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights

07 Mar 2023 06:00:56 By Nasdaq GlobeNewswire

Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results

28 Feb 2023 15:30:00 By Nasdaq GlobeNewswire

Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion

21 Feb 2023 06:00:01 By Nasdaq GlobeNewswire

Optinose Announces CEO Transition and Business Update

31 Jan 2023 06:00:01 By Nasdaq GlobeNewswire

Optinose Appoints Paul Spence as Chief Commercial Officer

15 Dec 2022 15:30:00 By Nasdaq GlobeNewswire

Optinose Announces Departure of Acting Chief Financial Officer

09 Dec 2022 07:00:00 By Nasdaq GlobeNewswire

Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference

30 Nov 2022 06:00:00 By Nasdaq GlobeNewswire